Christen Skolnick, LCSW | |
24988 Se Stark St Ste 140, Mail Code: Cmng, Gresham, OR 97030-8326 | |
(971) 262-9806 | |
(971) 262-9501 |
Full Name | Christen Skolnick |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 24988 Se Stark St Ste 140, Gresham, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093170342 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | L5312 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christen Skolnick, LCSW 24988 Se Stark St Ste 140, Mail Code: Cmng, Gresham, OR 97030-8326 Ph: (971) 262-9806 | Christen Skolnick, LCSW 24988 Se Stark St Ste 140, Mail Code: Cmng, Gresham, OR 97030-8326 Ph: (971) 262-9806 |
News Archive
I still harbor the perhaps naïve hope that some conservative justices - Anthony Kennedy? John Roberts? -; will pull back from judicial activism and allow the voters to decide the fate of the health-care law in this fall's elections. And here is where the court's reintroduction of the health-care issue into the political debate could be turned into a blessing by allies of reform, provided they take advantage of the opportunity to do what they have never done adequately up to now. They need, finally, to describe and defend the law and what it does.
As the World Health Organization steps up its efforts to eradicate a once-rampant tropical disease, a University of Washington study suggests that monitoring, and potentially treating, the monkeys that co-exist with humans in affected parts of the world may be part of the global strategy.
Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that the company raised $35.5 million in a Series E financing based on encouraging clinical progress and investor support for galeterone (TOK-001), Tokai's lead prostate cancer drug candidate.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P."
› Verified 6 days ago
Matthew Joseph Bartolotti, LSCW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 400 Ne 7th St, Gresham, OR 97030 Phone: 503-489-2236 | |
Ryely Wilpone, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 600 Ne 8th St, Gresham, OR 97030 Phone: 503-988-5155 Fax: 503-988-5185 | |
Jamie Nash-sedda, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2970 Ne 7th St, Gresham, OR 97030 Phone: 509-863-4560 | |
James Macleod, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4101 Ne Division St, Gresham, OR 97030 Phone: 971-284-1963 | |
Alyssa Wirthlin, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 400 Ne 7th St, Gresham, OR 97030 Phone: 503-661-5455 | |
Colette Renee Deleon, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1217 Ne Burnside Rd, Building B Suite 401, Gresham, OR 97030 Phone: 503-666-8832 Fax: 503-669-8641 |